Carotid Artery Stenting Linked to High Mortality Rate

Stent
Stent
Patients aged older than 80 years were at an especially high risk.

Carotid stenting was associated with much higher than expected 2-year mortality in the Medicare population, a national analysis found.

That rate was 32% in the CMS carotid artery stenting database (CAS-D) from 2005 to 2009, Soko Setoguchi, MD, DrPH, of the Duke Clinical Research Institute, and colleagues reported online in JAMA Neurology.

In the CREST trial, mortality was 11.3% after a median follow-up of 2.5 years. In SAPPHIRE, it was 20% after 3 years. The researchers concluded that those trials might have limited generalizability to the Medicare population and called for real-world effectiveness studies comparing the percutaneous treatment to surgery and to medical management.

READ FULL ARTICLE Curated publisher From Medical Page Today